COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY
This article was originally published in The Tan Sheet
Executive Summary
COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY, who will "direct the company's regulatory affairs, research and product development programs," the Canton, Mass.-based generic drug company announced Nov. 9. Jerome Skelly, PhD, spent 20 years with FDA, most recently as deputy director for the Center for Drug Evaluation & Research's Office of Research Resources, where, Copley said, he was responsible for "developing and improving systems and procedures for verifying data submitted to FDA," Copley said.